Sign in
Back
Trying to outRun‐DIC in KMT2Ar AML: It's tricky
Journal article   Peer reviewed

Trying to outRun‐DIC in KMT2Ar AML: It's tricky

Sangeetha Venugopal and Justin Taylor
Cancer, Vol.129(12), pp.1797-1799
2023-06-15
DOI: https://doi.org/10.1002/cncr.34727
PMID: 36892942
Appears in  Miller School of Medicine - Latest Publications

Abstract

acute myeloid leukemia bleeding disseminated intravascular coagulation KMT2A leukemia
In this issue of Cancer, Nguyen and colleagues describe high risk of disseminated intravascular coagulation (DIC) in patients with KMT2Ar acute myeloid leukemia (AML) compared with matched controls in a retrospective single‐institution analysis. The authors of this editorial put this study into perspective of other AML subtypes at high risk of DIC and bleeding.

Metrics

11 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.103 Blood Disorders
1.103.155 Acute Myeloid Leukemia
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details